.
New Delhi, April 21 (MondayMirror.com) The expert panel of India’s apex drug regulator on Thursday recommended grant of emergency use authorisation to Covid vaccine Corbevax for those in the 5-12 years age bracket.
According to a source familiar with the development, the Subject Expert Committee has recommended Drug Controller General of India grant the emergency use authorisation to Hyderabad-based Biological E’s Corbevax for this age. However, the emergency use authorisation may be the subject of certain conditions, the source added.
Earlier in the day, the panel held a meeting to discuss the recommendations on restricted emergency use of Bharat Biotech’s Covaxin and Biological E’s Corbevax vaccines among children aged 5-12.
The SEC has sent the recommendations to the DCGI. After the DCGI’s nod to the recommendation, the Union Health Ministry may give final approval to begin the vaccination for this age group.
Corbevax vaccine is India’s first indigenously-developed protein sub-unit vaccine against Covid-19. This vaccine is currently being administered to children in the age group 12-14 years.
Source: IANS
To make a wave in the digital entertainment world, a new OTT platform, Oceaniek Stream,…
Punjab Governor & Administrator Chandigarh (UT) Gulab Chand Kataria inaugurates event India's leading industry body,…
A protest was organized by members of the Chandigarh wheelchair cricket team and residents ,…
The 10th GTA Cup Open National Taekwondo Championship, organized by Emerald Martial Arts Academy, successfully…
As we step into 2025, the world of OTT entertainment continues to deliver thrilling and…
Bollywood, the heart of India’s entertainment industry, has been shaped by its music just as…